This compound is a protected piperidine amino acid derivative designed for use as a pharmaceutical intermediate in peptide and small-molecule synthesis. Its structure incorporates a fluorenylmethoxycarbonyl (Fmoc) protecting group and a tert-butyl ether, enabling selective deprotection steps during drug manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Fmoc-4-tert-butoxy-L-proline
research compound
N-Fmoc-(2S,5S)-5-tert-butoxypipecolicacid
pharmaceutical intermediate
(2S,5R)-5-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
3,4-Dichlorobenzoyl chloride
pharmaceutical intermediate
(3R,4S)-3-[(3S)-3-(4-Fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-1-phenylazetidin-2-one
pharmaceutical intermediate
2-[(tert-Butoxycarbonyl)amino]-1,3-thiazole-5-carboxylic acid
pharmaceutical intermediate
N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide
pharmaceutical intermediate
(2S,4S)-4-tert-butoxy-1-(9H-fluoren-9-ylmethoxycarbonyl)piperidine-2-carboxylic acid
pharmaceutical intermediate
(2S,4R)-1-(9H-fluoren-9-ylmethoxycarbonyl)-4-[(2-methylpropan-2-yl)oxy]piperidine-2-carboxylic acid
CVDIZXJOPDKIAY-ZHRRBRCNSA-N
CC(C)(C)O[C@@H]1CCN([C@@H](C1)C(=O)O)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.